Find the Perfect Plan for Your Investment Journey
C
Latest price
52 Week Range
$0.55 - $49.00
Next Earnings Date
May 09 2025
Next Earnings Date
May 09 2025
Latest price
Market Cap | $47.94M |
EV | $51.74M |
Shares Outstanding | 71.55M |
Beta | -0.19 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $3.00 |
P/E 2025E | - |
P/Revenue 2025E | 1.67x |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 70.00% |
Net Profit Margin 2025E | -78.48% |
ROE 2025E | - |
ROCE 2024 | -59.01% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
C
Citius Oncology, Inc.
CTOR
Sector
Industry
CEO
Mazur, Leonard
Employees
Website
Data UnavailableIPO Date
Headquarters
420 Lexington Avenue, Suite 2446, New York, New York, 10170, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved